Mesoblast Newsroom

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18

Futu NewsNov 6 21:39

Buy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for Ryoncil

TipRanksNov 6 20:47

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11

Futu NewsOct 31 19:31

Mesoblast Price Target Announced at $12.00/Share by Maxim Group

Dow JonesSep 24 21:13

Maxim Group Upgrades Mesoblast(MESO.US) to Buy Rating, Cuts Target Price to $12

Futu NewsSep 24 20:32

Bell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF)

TipRanksAug 30 10:10

Mesoblast Analyst Ratings

BenzingaAug 29 23:19

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Announces Target Price $11

Futu NewsAug 29 19:32

Mesoblast (MESO) Receives a Buy From Piper Sandler

TipRanksAug 29 18:52

Mesoblast Analyst Ratings

BenzingaJul 24 01:57

Piper Sandler Upgrades Mesoblast to Overweight, Raises Price Target to $11

BenzingaJul 24 01:57

Piper Sandler Upgrades Mesoblast(MESO.US) to Buy Rating

Futu NewsJul 24 01:32

Mesoblast Limited (MEOBF) Was Downgraded to a Hold Rating at Jefferies

TipRanksJul 18 20:23

Mesoblast Analyst Ratings

BenzingaJun 21 01:42

Mesoblast Analyst Ratings

BenzingaJun 5 01:25

Analysts Offer Insights on Healthcare Companies: Aprea Therapeutics (APRE), Biogen (BIIB) and Mesoblast Limited (OtherMEOBF)

TipRanksMar 27 20:25

Mesoblast (MESO) Gets a Hold From Piper Sandler

TipRanksMar 12 18:36

Mesoblast Limited (MEOBF) Receives a Buy From Jefferies

TipRanksMar 3 20:16

Mesoblast (MESO) Gets a Hold From Piper Sandler

TipRanksFeb 29 20:48

Jefferies Keeps Their Buy Rating on Mesoblast Limited (MEOBF)

TipRanksDec 26, 2023 20:38